The investment seeks long-term capital appreciation... Show more
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Category ForeignLargeGrowth
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
CNCR | 9.12 | 0.27 | +3.05% |
Range Cancer Therapeutics ETF | |||
FNK | 49.24 | 0.97 | +2.01% |
First Trust Mid Cap Value AlphaDEX® ETF | |||
IMCG | 74.44 | 0.91 | +1.24% |
iShares Morningstar Mid-Cap Growth ETF | |||
QARP | 50.90 | 0.17 | +0.34% |
Xtrackers Russell 1000 US QARP ETF | |||
YYY | 11.21 | 0.02 | +0.18% |
Amplify High Income ETF |
A.I.dvisor indicates that over the last year, TPYAX has been closely correlated with VTSNX. These tickers have moved in lockstep 88% of the time. This A.I.-generated data suggests there is a high statistical probability that if TPYAX jumps, then VTSNX could also see price increases.
Ticker / NAME | Correlation To TPYAX | 1D Price Change % | ||
---|---|---|---|---|
TPYAX | 100% | N/A | ||
VTSNX - TPYAX | 88% Closely correlated | N/A | ||
VTISX - TPYAX | 88% Closely correlated | N/A | ||
VTIAX - TPYAX | 87% Closely correlated | N/A | ||
VTPSX - TPYAX | 86% Closely correlated | N/A | ||
VGTSX - TPYAX | 86% Closely correlated | N/A | ||
More |